Objective: The aim of this study was to estimate the recurrence risk based on the number of
prognostic factors for patients with stage I uterine endometrioid carcinoma (EC) who …

Purpose/Objective (s) To estimate the recurrence risk based on the number of prognostic
factors in women with FIGO stage I uterine endometrioid carcinoma (EC) in a large cohort of …

Purpose/Objective (s) Substantiallymphovascular space invasion (LVSI) is an important
predictor of lymph node involvement in women with endometrial carcinoma. However, its …

Objective There is paucity of data in regard to prognostic factors and outcome of women with
2009 FIGO stage II disease. The objective of this study was to investigate prognostic factors …

Objective: The aim of this study was to evaluate clinicopathologic factors affecting disease
recurrence in patients with FIGO stage I-II endometrial cancer. Method: We retrospectively …

Objectives: Evaluate if the addition of adjuvant chemotherapy to radiation therapy improves
survival of patients with high-intermediate stage I endometrioid endometrial carcinoma with …

OBJECTIVES: Investigate the clinicopathologic characteristics, nodal distribution, and
postoperative treatment of patients with FIGO stage IIIC endometrial carcinoma and …

OBJECTIVES: Controversy continues over the importance of lymph node (LN) status in
treating and predicting recurrence in endometrial cancer. Several predictive models are …

Objective: The goal was to develop an updated model to predict the risk of recurrence,
based on the number of adverse pathologic features in women with International Federation …

Objectives The role of pelvic lymphadenectomy (LA) in women with stage I endometrial
carcinoma (EC) is controversial. The objective of this study is to investigate the prognostic …